GE HealthCare Technologies Inc
For the period ended Sep 30, 2024. Filed Oct 30, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 30, 2024
GEHC$83.65-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Financial Position
| Condensed Consolidated Statements of Financial Position (Unaudited) | ||
|---|---|---|
| As of | ||
| (In millions, except share and per share amounts) | September 30, 2024 | December 31, 2023 |
| Cash, cash equivalents, and restricted cash | $3,568 | $2,504 |
| Receivables – net of allowances of $104 and $98 | 3,418 | 3,525 |
| Due from related parties | 6 | 32 |
| Inventories | 2,124 | 1,960 |
| Contract and other deferred assets | 1,046 | 1,000 |
| All other current assets | 476 | 389 |
| Current assets | 10,638 | 9,410 |
| Property, plant, and equipment – net | 2,539 | 2,500 |
| Goodwill | 13,138 | 12,936 |
| Other intangible assets – net | 1,132 | 1,253 |
| Deferred income taxes | 4,309 | 4,474 |
| All other non-current assets | 2,098 | 1,881 |
| Total assets | $33,855 | $32,454 |
| Short-term borrowings | $1,007 | $1,006 |
| Accounts payable | 2,911 | 2,947 |
| Due to related parties | 7 | 99 |
| Contract liabilities | 1,915 | 1,918 |
| Current compensation and benefits | 1,422 | 1,518 |
| All other current liabilities | 1,409 | 1,493 |
| Current liabilities | 8,670 | 8,981 |
| Long-term borrowings | 9,306 | 8,436 |
| Non-current compensation and benefits | 5,388 | 5,782 |
| Deferred income taxes | 59 | 68 |
| All other non-current liabilities | 1,920 | 1,877 |
| Total liabilities | 25,343 | 25,144 |
| Commitments and contingencies | ||
| Redeemable noncontrolling interests | 177 | 165 |
| Common stock, par value $0.01 per share, 1,000,000,000 shares authorized, 457,144,443 shares issued as of September 30, 2024; 455,342,290 shares issued as of December 31, 2023 | 5 | 5 |
| Treasury stock, at cost, 291,053 shares as of September 30, 2024 and 0 shares as of December 31, 2023 | (25) | — |
| Additional paid-in capital | 6,551 | 6,493 |
| Retained earnings | 2,558 | 1,326 |
| Accumulated other comprehensive income (loss) – net | (771) | (691) |
| Total equity attributable to GE HealthCare | 8,317 | 7,133 |
| Noncontrolling interests | 18 | 12 |
| Total equity | 8,335 | 7,145 |
| Total liabilities, redeemable noncontrolling interests, and equity | $33,855 | $32,454 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.